CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides

L McGeoch, M Twilt, L Famorca, V Bakowsky… - The Journal of …, 2016 - jrheum.org
Objective. The Canadian Vasculitis research network (CanVasc) is composed of physicians
from different medical specialties and researchers with expertise in vasculitis. One of its aims …

[HTML][HTML] Transancestral mapping and genetic load in systemic lupus erythematosus

CD Langefeld, HC Ainsworth, DSC Graham… - Nature …, 2017 - nature.com
Systemic lupus erythematosus (SLE) is an autoimmune disease with marked gender and
ethnic disparities. We report a large transancestral association study of SLE using …

Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE)

S Bernatsky, M Fournier, CA Pineau… - Environmental …, 2011 - ehp.niehs.nih.gov
Background Systemic lupus erythematosus (SLE) is a chronic disease of unclear etiology,
characterized by an overactive immune system and the production of antibodies that may …

Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?

I Karp, M Abrahamowicz, PR Fortin… - Arthritis Care & …, 2008 - Wiley Online Library
Objective Systemic lupus erythematosus (SLE) is characterized by a markedly elevated risk
for coronary heart disease (CHD), the exact pathogenesis of which is unknown. In particular …

Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population‐based cohort

É Vinet, CA Pineau, AE Clarke, S Scott… - Arthritis & …, 2015 - Wiley Online Library
Objective In utero exposure to maternal antibodies and cytokines are potential risk factors for
autism spectrum disorders (ASDs). The aim of this study was to determine whether children …

[HTML][HTML] Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings …

Z Touma, A Sayani, CA Pineau, I Fortin… - Rheumatology …, 2017 - Springer
To describe the characteristics of patients receiving belimumab, overall patterns of systemic
lupus erythematosus (SLE) care, clinical outcomes, and changes in glucocorticoid dose …

Prolonged corrected QT interval in anti‐Ro/SSA–positive adults with systemic lupus erythematosus

J Bourré‐Tessier, AE Clarke, T Huynh… - Arthritis Care & …, 2011 - Wiley Online Library
Objective To examine whether anti‐Ro/SSA antibodies are associated with an increased
risk of corrected QT (QTc) prolongation, and to study the stability of this relationship over …

CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update

A Mendel, D Ennis, E Go, V Bakowsky… - The Journal of …, 2021 - jrheum.org
Objective In 2015, the Canadian Vasculitis Research Network (CanVasc) created
recommendations for the management of antineutrophil cytoplasm antibody (ANCA) …

Risk of ocular anomalies in children exposed in utero to antimalarials: a systematic literature review

R Gaffar, CA Pineau, S Bernatsky… - Arthritis care & …, 2019 - Wiley Online Library
Objective To determine whether offspring from mothers with systemic lupus erythematosus
(SLE), exposed in utero to antimalarials, have an increased risk of ocular anomalies during …

Arterial events in persons with dermatomyositis and polymyositis

A Tisseverasinghe, S Bernatsky… - The Journal of …, 2009 - jrheum.org
Objective. To assess arterial events in dermatomyositis (DM) and polymyositis (PM), and
associated factors. Methods. We studied a cohort of persons with DM and PM, assembled …